Dicarboxylic aciduria and medium chain triglyceride supplemented milk

Area of Science:

• Biochemistry
• Neonatal Medicine
• Metabolic Disorders

Background:

• Specialized infant formulas often include medium chain triglycerides (MCTs).
• The metabolic consequences of MCT supplementation in vulnerable populations like preterm infants require careful consideration.
• Dicarboxylic acids are metabolic byproducts with potential toxicities.

Purpose of the Study:

• To investigate the metabolic effects of MCT-supplemented formula in preterm infants.
• To assess the incidence of dicarboxylic aciduria in this population.
• To raise awareness about the diagnostic implications for inborn errors of metabolism.

Main Methods:

• Observational study of preterm infants.
• Analysis of urine samples for dicarboxylic acid levels.
• Comparison of infants fed standard versus MCT-supplemented formula.

Main Results:

• Preterm infants fed MCT-supplemented formula exhibited pronounced dicarboxylic aciduria.
• Elevated levels of dicarboxylic acids were consistently detected.
• No significant differences were noted in infants on standard formula (implied).

Conclusions:

• MCT supplementation in infant formula can lead to significant dicarboxylic aciduria.
• This finding necessitates attention to the metabolic effects of MCTs in neonatal nutrition.
• Dicarboxylic aciduria may complicate the diagnosis of inborn errors of metabolism and warrants further investigation regarding potential harm.